Revenue recognized from prior periods

Name: Halozyme Therapeutics Revenue recognized from prior periods by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Halozyme Therapeutics·Products & Services·1 segment·Rolls up to Impact to revenue from performance obligations satisfied (or partially satisfied) in previous periods

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
License Fees and Event-Based	$150.4M	$173.1M	$215.4M	$183.2M	$240.1M	$256M	$305.4M	$240.7M
Total	—	—	—	—	—	—	—	—

Segments

License Fees and Event-BasedView metric